Clinical trial NCT06575972: A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.
Official title: A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Alcohol Aftereffects
Anxiety
Cognitive Impairment
Keywords: Cognitive Function
Hangover
Anxiety Reduction
Lead sponsor: Joyrise
Sponsor class: INDUSTRY
Collaborators: name: Citruslabs
First posted: 2024-08-28
Enrollment: 60
Sex: ALL
Minimum age (years): 35
Maximum age (years): 54
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: This is a randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy of JoyRise Recovery Powder in mitigating the aftereffects of alcohol consumption. The study involves two groups: one receiving the active supplement (JoyRise Recovery Powder) and the other receiving a placebo.
Primary purpose: TREATMENT

Brief summary: This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.


Eligibility criteria: Inclusion Criteria:

* Aged 35-54, male or female
* Regular alcohol consumption
* Event planned within one month that involves alcohol consumption
* Willingness to avoid new medications or supplements during the study period
* Must confirm that they will not drive while under the influence of alcohol.

Exclusion Criteria:

* Anyone not in good health.
* Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
* Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
* Anyone who is pregnant, breastfeeding, or trying to conceive.
* Anyone who cannot/ will not commit to the study protocol.
* Anyone with a history of substance abuse.
* Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration.
* Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension.
* History of severe reactions or sensitivity to alcohol.
* Anyone currently taking glutathione.

Primary outcomes:
measure: Reduction in Symptoms Associated with Alcohol Aftereffects
timeFrame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.
Secondary outcomes:
measure: Improvement in Cognitive Function
timeFrame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.
measure: Improvement in Cognitive Function
timeFrame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.
measure: Reduction in Feelings of Anxiousness
timeFrame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.
measure: Increased User Satisfaction with Overall Well-being
timeFrame: Baseline and 4+ hours after product consumption on the day following alcohol consumption.
Other outcomes:
Locations:
city: Santa Monica
country: United States
facility: Citruslabs
state: California
Study officials:
References: